Xenon Pharmaceuticals (XENE) Shares Issued (2013 - 2026)
Xenon Pharmaceuticals (XENE) posted quarterly Shares Issued of $5.7 million for Q1 2026, down 13.18% year-over-year from $6.5 million in Q1 2025, and down 48.67% quarter-over-quarter from $11.1 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Shares Issued (2013 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has reported Shares Issued for 14 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued fell 13.18% year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (down 13.18% YoY), while the FY2025 annual figure was $11.1 million, up 3.41% from the prior year.
- Shares Issued fell to $5.7 million in Q1 2026 per XENE's latest filing, from $11.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $11.2 million in Q3 2025 and bottomed at $3.4 million in Q3 2022.
- Historically, Shares Issued has averaged $7.6 million across 5 years, with a median of $7.1 million in 2022.
- Annual changes were most pronounced in 2022 — Shares Issued slumped 42.71% — and 2024, when it jumped 160.18%.
- Xenon Pharmaceuticals' Shares Issued stood at $7.1 million in 2022, then grew by 24.96% to $8.9 million in 2023, then rose by 20.4% to $10.7 million in 2024, then climbed by 3.41% to $11.1 million in 2025, then sank by 48.67% to $5.7 million in 2026.
- Business Quant data shows XENE's Shares Issued at $5.7 million in Q1 2026, $11.1 million in Q4 2025, and $11.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Xenon Pharmaceuticals | 6.03 Bn | 6.03 Bn | - | 11.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.81 Mn |
| Jun 30, 2026 | 11.81 Mn |
| Mar 31, 2026 | 5.68 Mn |
| Mar 31, 2026 | 5.68 Mn |
| Dec 31, 2025 | 11.07 Mn |
| Dec 31, 2025 | 11.07 Mn |
| Sep 30, 2025 | 11.18 Mn |
| Sep 30, 2025 | 11.18 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Jun 30, 2025 | 6.29 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Mar 31, 2025 | 6.55 Mn |
| Dec 31, 2024 | 10.71 Mn |
| Dec 31, 2024 | 10.71 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Jun 30, 2024 | 10.78 Mn |
| Mar 31, 2024 | 10.68 Mn |
| Mar 31, 2024 | 10.68 Mn |